Kenvue shows decent growth but struggles with profitability. Find out why KVUE stock is a 'hold' as cost-cutting efforts face ...

NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags. Read more on NRXS stock here.

After the Nifty ended the previous session at 23,696.30, a decrease of 0.18%, the early Gift Nifty movement on Thursday ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, acting ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

“Today’s approval is an important public health milestone in acute pain management,” said Jacqueline Corrigan-Curay, MD, acting director of the FDA’s Center for Drug Evaluation and ...

Well, Amazon shoppers have found a genius solution that stops chronic neck pain for a comfortable sleep. The Coop Home Goods Crescent Pillow is topping Amazon’s Movers and Shakers chart ...

DISC Sports & Spine Center ("DISC") proudly announces that 20 of its physicians are being recognized this year by The Southern California Super Doctors®. These honors follow a rigorous, multi-phase ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

Anybody who’s had to grapple with turning a spreadsheet jam-packed with raw data into a killer chart or graph will rejoice ... application will help take the pain out a critical business ...